» Articles » PMID: 10449973

Recommendation for the Examination of Pancreaticoduodenectomy Specimens Removed from Patients with Carcinoma of the Exocrine Pancreas. A Proposal for a Standardized Pathological Staging of Pancreaticoduodenectomy Specimens Including a Checklist

Overview
Journal Dig Surg
Date 1999 Aug 18
PMID 10449973
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The prognosis of ductal adenocarcinoma of the pancreas is poor. Despite many attempts at a more aggressive surgical approach, tumor recurrence rates of around 80% are common. For various reasons, most of the studies on the subject are difficult to compare. Not only do the surgical techniques vary, but, more importantly, the methods used for processing the specimens and for the pathological examination differ. If we are to improve the situation, it would appear imperative to standardize procedures. Standardized pathological staging of pancreaticoduodenectomy specimens should be performed mainly with reference to the guidelines of the WHO and UICC, with optional staging of the lymph nodes according to their anatomical site. Precise definition and accurate examination of the resection margins, especially of that towards the retroperitoneum, is essential for a better comparison of the results of the different therapeutic strategies and approaches to pancreatic carcinoma.

Citing Articles

Malignant epithelial/exocrine tumors of the pancreas.

Luchini C, Grillo F, Fassan M, Vanoli A, Capelli P, Paolino G Pathologica. 2020; 112(3):210-226.

PMID: 33179623 PMC: 7931574. DOI: 10.32074/1591-951X-167.


Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma.

Al-Zoughbi W, Schauer S, Pichler M, Hoefler G Pathobiology. 2018; 85(5-6):342-347.

PMID: 30227407 PMC: 6390459. DOI: 10.1159/000492433.


Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3:....

Saka B, Balci S, Basturk O, Bagci P, Postlewait L, Maithel S Ann Surg Oncol. 2016; 23(6):2010-8.

PMID: 26832882 PMC: 5389382. DOI: 10.1245/s10434-016-5093-7.


Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets.

Casadei R, di Marco M, Ricci C, Santini D, Serra C, Calculli L J Gastrointest Surg. 2015; 19(10):1802-12.

PMID: 26224039 DOI: 10.1007/s11605-015-2890-4.


Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer.

Kim H, Park C, Lee J, Kim J, Cho C, Kim H Ann Surg Treat Res. 2015; 88(4):200-7.

PMID: 25844354 PMC: 4384285. DOI: 10.4174/astr.2015.88.4.200.